Informações:
Falhas:
ID
34555
Descrição
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01251120
Link
https://clinicaltrials.gov/show/NCT01251120
Palavras-chave
Versões (1)
- 19/01/2019 19/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
19 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Rheumatoid Arthritis NCT01251120
Eligibility Rheumatoid Arthritis NCT01251120
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01251120
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
adult patients, over the age of 18 years
boolean
ID.2
Item
diagnosis of moderate-to-severe active early rheumatoid arthritis (ra) of less than 2 years duration
boolean
ID.3
Item
das28 >3.2
boolean
ID.4
Item
swollen joint count (sjc) >/=6 (66 joint count), and tender joint count (tjc) >/=6 (68 joint count)
boolean
ID.5
Item
patients who have received dmards (including methotrexate) for 3-7 months
boolean
ID.6
Item
major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months after baseline
boolean
ID.7
Item
rheumatic autoimmune disease other than rheumatoid arthritis (secondary sjögrens syndrome or nodulosis with ra is permitted)
boolean
ID.8
Item
functional class iii or iv as defined by acr classification of functional status in rheumatoid arthritis
boolean
ID.9
Item
prior history of or current inflammatory joint disease other than ra
boolean